Cite
HARVARD Citation
Norris, R. et al. (n.d.). Phase 1 evaluation of EZN‐2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors. Pediatric blood & cancer. 61 (10), pp. 1792-1797. [Online].